相关实验视频

Updated: Sep 10, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

阻断Fpr3通过抑制NLRP3介导的软骨细胞亡来缓解关节炎

Bin Zhou¹, Yaobin Huang¹

¹Department of Joint Orthopaedics, Yuebei people's hospital, Shaoguan, Guangdong 512000, China.

|August 23, 2025

概括

阻断甲基受体3 (Fpr3) 降低了骨关节炎的进展和冠状腺炎. 针对Fpr3可能为这种常见关节疾病提供新的治疗策略.

科学领域:

生物医学
炎症研究
骨关节炎的发生

背景情况:

骨关节炎 (OA) 是老年人常见的一种退行性关节疾病.
甲基受体3 (Fpr3) 在OA和状细胞灭中的作用尚不清楚.
炎症是OA进展的一个关键因素.

研究的目的:

调查Fpr3在骨关节炎和冠状腺炎中所扮演的角色.
探索Fpr3作为关节炎的治疗点的潜力.

主要方法:

在小鼠模型中使用前交叉带切割 (ACLT) 来诱导OA.
使用脂聚糖 (LPS) 来刺激肌肉细胞的炎症.
评估了Fpr3表达水平,冠状体标志物,代谢因子,炎症细胞因子和NLRP3炎症组分.

主要成果:

在接受OA治疗的小鼠和LPS治疗的冠状细胞中,Fpr3表达升高.
降低Fpr3可以减轻胆固醇细胞损伤,增强胆固醇标志物,抑制代谢因子和炎症媒介.
此外,Fpr3抑制也降低了NLRP3炎症酶通路的激活.

结论:

抑制Fpr3可以缓解骨关节炎的细胞外基质降解和炎症.
Fpr3阻断的保护作用通过NLRP3炎症体通路进行介导.
调节Fpr3为关节炎治疗提供了一个有前途的治疗途径.

关键词:

其他类型在NLRP3 骨关节炎

更多相关视频

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

相关概念视频

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...